Zurich cannabis study receives positive assessment
Select your language
Generated with artificial intelligence.
Listening: Zurich cannabis study receives positive assessment
Health officials in the city of Zurich have given a positive assessment of a controlled study into the recreational use of cannabis, one year after it was launched.
“Our approach places the health of cannabis users at the centre and shows that modern prevention work can go hand in hand with controlled access to cannabis products,” declared Andreas Hauri, a member of the city government in charge of public health, in a press release issued on Thursday by the city of Zurich, the University of Zurich and the University Psychiatric Clinic Zurich.
Around 2,100 people have taken part in the pilot project approved by the Swiss federal authorities. Of these, 150 people have stopped participating. Over half of participants consume cannabis at least four times a week.
Over a 12-month period, a total of 300kg of cannabis products were sold to participants in Zurich in 21 pharmacies, social clubs and drug information centres in the city under the pilot scheme. A total of 36,000 sales of hashish and dried cannabis flowers were recorded.
The pilot project is scheduled to run until October 2026. A number of similar recreational cannabis studies are underway in several Swiss cities and cantons.
Translated from French by DeepL/sb
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Multinational companies
Azeri fossil-fuel cash cow brings controversy to Switzerland
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.